Soon, simple blood test to detect early stages of breast cancer
Washington: A new research has suggested that early stages of breast cancer could soon be diagnosed from blood samples.
Houston Methodist Research Institute scientists, who are developing the technology, said that what could someday be the first blood test for the early detection of breast cancer was shown in preliminary studies to successfully identify the presence of breast cancer cells from serum biomarkers.
With a New York University Cancer Institute colleague, the researchers reported that the mixture of free-floating blood proteins created by the enzyme carboxypeptidase N accurately predicted the presence of early-stage breast cancer tissue in mice and in a small population of human patients.
"In this paper we link the catalytic activity of carboxypeptidase N to tumor progression in clinical samples from breast cancer patients and a breast cancer animal model. Our results indicate that circulating peptides generated by CPN can serve as clear signatures of early disease onset and progression," biomedical engineer Tony Hu , Ph.D., who led the project, said.
The technology is not yet available to the public, and may not be for years. More extensive clinical tests are needed, and those tests are expected to begin in early 2014.
There are currently no inexpensive laboratory tests for the early detection of breast cancer, providing the impetus for researchers around the world to invent them.
"What we are trying to create is a non-invasive test that profiles what's going on at a tissue site without having to do a biopsy or costly imaging," Hu said. "We think this could be better for patients and-if we are successful-a lot cheaper than the technology that exists."
CPN is an enzyme that modifies proteins after the proteins are first created. Past studies have only shown the enzyme is more active in lung cancer patients.
The technology being developed by Hu's group combines nanotechnology and advanced mass spectrometry to separate and detect extremely low levels of small proteins (peptides) created by CPN. These peptides are believed to originate in or near cancerous cells, eventually making their way into the bloodstream.
The study is published in Clinical Chemistry.
More from India
More from World
More from Sports
More from Entertaiment
- DNA: Analysis of public pulse through survey by Zee News on Bihar elections
- DNA: End of ISIS? Vladimir Putin to send 1,50,000 soldiers to Syria
- Russia surprises America with accord on battling ISIS
- Panel discussion on Muslim vote bank in Bihar elections
- Bihar polls: Lalu's younger son claims to be older than elder brother
- India vs South Africa: How cricket fraternity reacted to crowd's disgraceful behaviour at Cuttack
- Salman Khan, Aamir Khan's friendship turns sour? Here's the truth
- BJP-led NDA predicted to win 147 seats in Bihar Assembly Elections: Survey
- Dadri lynching: Any threat to secular fabric of country would not be tolerated, says Rajnath Singh
- Can Lalu Prasad Yadav's elder son Tej be less in age than younger son Tejaswi?